Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer.
about
Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Clinical outcome of patients w ...... nt for advanced kidney cancer.
@en
Clinical outcome of patients w ...... nt for advanced kidney cancer.
@nl
type
label
Clinical outcome of patients w ...... nt for advanced kidney cancer.
@en
Clinical outcome of patients w ...... nt for advanced kidney cancer.
@nl
prefLabel
Clinical outcome of patients w ...... nt for advanced kidney cancer.
@en
Clinical outcome of patients w ...... nt for advanced kidney cancer.
@nl
P2093
P50
P1433
P1476
Clinical outcome of patients w ...... ent for advanced kidney cancer
@en
P2093
Alessandra Mosca
Alessandro Pastorino
Andrea Ardizzoni
Annalisa Guida
Carmine Pinto
Elisa Biasco
Franco Nolè
Giampaolo Tortora
Giuseppe Fornarini
Luca Galli
P304
541.e7-541.e13
P356
10.1016/J.UROLONC.2017.05.007
P50
P577
2017-05-29T00:00:00Z